| 製品番号 |
製品名 |
製品効果
|
純度 |
Rare Diseases
|
| HY-B2060A |
Tiamulin fumarate |
Inhibitor |
99.27% |
Unkown |
| HY-113491 |
3-Phosphoglyceric acid |
Chemical |
99.88% |
Unkown |
| HY-B2060 |
Tiamulin |
Inhibitor |
99.74% |
Unkown |
| HY-RS13702 |
SPP1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS16219 |
SPP1 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-126491 |
SPP-DM1 |
|
96.29% |
Unkown |
| HY-Y0760 |
3-Methoxybenzoic acid |
|
99.61% |
Unkown |
| HY-N6695 |
Aflatoxicol |
|
99.9% |
Unkown |
| HY-W019901B |
Anhydrous calcium sulfate (97%) |
Activator |
99.40% |
Unkown |
| HY-P4613 |
Fmoc-D-allo-Thr-OH |
|
/ |
Unkown |
| HY-136380 |
Clodinafop-propargyl |
|
98.0% |
Unkown |
| HY-116479 |
Citromycetin |
Inhibitor |
99.1% |
Unkown |
| HY-12613 |
2-C-methylene-myo-inositol oxide |
|
/ |
Unkown |
| HY-139746 |
FPI-1602 |
Inhibitor |
/ |
Unkown |
| HY-164207 |
VLPA-GlcNAc |
|
/ |
Unkown |
| HY-N2340A |
D-(+)-Melezitose hydrate |
|
98.0% |
Unkown |
| HY-N2728 |
6-O-Syringoylajugol |
|
/ |
Unkown |
| HY-P0068 |
Aminocandin |
Inhibitor |
/ |
Unkown |
| HY-P11187 |
Bactofencin A |
Inhibitor |
/ |
Unkown |
| HY-RS03413 |
CXXC1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS12810 |
SGPP1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W142497 |
3-Methyl-2(5H)-furanone |
|
97.34% |
Unkown |
| HY-W766785 |
Tiamulin Fumarate-13C4 |
|
/ |
Unkown |
| HY-Y0760R |
3-Methoxybenzoic acid (Standard) |
|
/ |
Unkown |
| HY-120729 |
Pyrazophos |
Inhibitor |
99.52% |
Unkown |
| HY-B2060S1 |
Tiamulin-d10-1 hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-N11995 |
allo-Aloeresin D |
|
/ |
Unkown |
| HY-N12882 |
(Z)-10-Hexadecen-1-ol |
|
/ |
Unkown |
| HY-N15183 |
Aselacin C |
|
/ |
Unkown |
| HY-RS22980 |
Spp1 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |